Search - tctmd.com

Displaying 561 - 580 of 785

Sort: Relevancy | Date

News Daily News

European Regulators Approve First Transcatheter MV Replacement Device

Michael O'Riordan

January 30, 2020

News Daily News

TAVR and Other Advanced CVD Therapies Used Less in Ontario Than NY State

Michael O'Riordan

January 22, 2020

News Daily News

Most Clinical Trial Sponsors Fail to Report Data as Mandated by FDA

Michael O'Riordan

January 21, 2020

News Daily News

Injectable GLP-1 Agonist Semaglutide Gets CVD Event Reduction Indication

Michael O'Riordan

January 17, 2020

News Daily News

Pricey, Unproven ‘Executive’ CVD Screening the Norm at Top US Hospitals

Michael O'Riordan

January 16, 2020

News Daily News

Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes

Michael O'Riordan

January 14, 2020

News Features

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Michael O'Riordan

January 10, 2020

News Daily News

New AUC for Cardiac Imaging Follow-up in Congenital Heart Disease

Michael O'Riordan

January 10, 2020

News Daily News

EACTS Offers to Help to Resolve EXCEL Controversy, as CRF Launches Review

Michael O'Riordan

January 08, 2020

News Daily News

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Michael O'Riordan

January 03, 2020

News Daily News

Speeding Cardiologists in Florida Most Likely to Drive ‘Luxury’ Cars

Michael O'Riordan

December 25, 2019

News Daily News

CvLPRIT: Long-term Reduction in Death/MI With Complete Revascularization

Michael O'Riordan

December 20, 2019

Taggart Rebuts EXCEL Response, Insisting on Retraction

News Daily News

Taggart Rebuts EXCEL Response, Insisting Concerns Over MI and Mortality Remain

Michael O'Riordan

December 18, 2019

News Daily News

Oxygen of No Benefit, Even in MI Patients With Low-Normal Saturation

Michael O'Riordan

December 16, 2019

News Features

EXCEL Investigators Respond to Data Suppression Claims as Debate Erupts Online

Michael O'Riordan

December 12, 2019

News Daily News

EACTS Pulls Out of Left Main Guidelines After BBC Bombshell Alleging EXCEL Trial Cover-up

Michael O'Riordan

December 10, 2019

News Daily News

Uninformed Consent? Most Patients Misunderstand True Benefits of PCI

Michael O'Riordan

November 29, 2019

News Daily News

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Michael O'Riordan

November 14, 2019

News Daily News

Lipid Levels Declining in US, With Drops Seen After 2013 Guideline Release

Michael O'Riordan

November 11, 2019

News Daily News

Sapien 3 Valve Approved in Europe for Low-Risk Patients

Michael O'Riordan

November 06, 2019

Advertisement

European Regulators Approve First Transcatheter MV Replacement Device

TAVR and Other Advanced CVD Therapies Used Less in Ontario Than NY State

Most Clinical Trial Sponsors Fail to Report Data as Mandated by FDA

Injectable GLP-1 Agonist Semaglutide Gets CVD Event Reduction Indication

Pricey, Unproven ‘Executive’ CVD Screening the Norm at Top US Hospitals

Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

New AUC for Cardiac Imaging Follow-up in Congenital Heart Disease

EACTS Offers to Help to Resolve EXCEL Controversy, as CRF Launches Review

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Speeding Cardiologists in Florida Most Likely to Drive ‘Luxury’ Cars

CvLPRIT: Long-term Reduction in Death/MI With Complete Revascularization

Taggart Rebuts EXCEL Response, Insisting Concerns Over MI and Mortality Remain

Oxygen of No Benefit, Even in MI Patients With Low-Normal Saturation

EXCEL Investigators Respond to Data Suppression Claims as Debate Erupts Online

EACTS Pulls Out of Left Main Guidelines After BBC Bombshell Alleging EXCEL Trial Cover-up

Uninformed Consent? Most Patients Misunderstand True Benefits of PCI

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Lipid Levels Declining in US, With Drops Seen After 2013 Guideline Release

Sapien 3 Valve Approved in Europe for Low-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content